NDANASALSPRAY, METERED
Approved
Jun 1996
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 3h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
VANCENASE AQ is a nasal corticosteroid spray containing beclomethasone dipropionate monohydrate, approved by FDA in 1996 for intranasal use. It is indicated for allergic and non-allergic rhinitis, reducing nasal inflammation and associated symptoms. The drug works as a topical corticosteroid that suppresses local immune and inflammatory responses in the nasal cavity.
LOE Approaching
With LOE approaching and moderate competitive pressure (30), this product requires focused lifecycle management and likely supports a smaller, efficiency-focused commercial team rather than growth-stage expansion.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
This product offers limited career growth opportunities given its LOE-approaching status and zero linked job openings. Professionals joining this brand typically focus on lifecycle management, competitive defense, and efficient portfolio stewardship rather than transformational innovation or team growth.
Product ManagerBrand Manager
Worked on VANCENASE AQ at Merck & Co.? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.